Published in Acta Oncol on January 01, 2006
The ethics of doing nothing. Suicide-bereavement and research: ethical and methodological considerations. Psychol Med (2013) 2.74
Bias in odds ratios by logistic regression modelling and sample size. BMC Med Res Methodol (2009) 1.86
Radiation Dose to the Penile Structures and Patient-Reported Sexual Dysfunction in Long-Term Prostate Cancer Survivors. J Sex Med (2015) 1.38
One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient. Support Care Cancer (2008) 1.00
Getting the grip on nonspecific treatment effects: emesis in patients randomized to acupuncture or sham compared to patients receiving standard care. PLoS One (2011) 0.86
Patient-reported sexual toxicity after radiation therapy in long-term prostate cancer survivors. Br J Cancer (2015) 0.83
Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study. Br J Cancer (2011) 0.83
Patient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy. Br J Cancer (2013) 0.82
Psychological morbidity among suicide-bereaved and non-bereaved parents: a nationwide population survey. BMJ Open (2013) 0.81
A Factor Analysis Approach for Clustering Patient Reported Outcomes. Methods Inf Med (2016) 0.78
Viewing the body after bereavement due to suicide: a population-based survey in Sweden. PLoS One (2014) 0.76
Physical activity before radical prostatectomy reduces sick leave after surgery - results from a prospective, non-randomized controlled clinical trial (LAPPRO). BMC Urol (2016) 0.75
Intrusive thoughts and quality of life among men with prostate cancer before and three months after surgery. Health Qual Life Outcomes (2013) 0.75
Adherence to medication: A nation-wide study from the Children's Cancer Hospital, Egypt. World J Psychiatry (2013) 0.75
Unresolved grief and its consequences. A nationwide follow-up of teenage loss of a parent to cancer 6-9 years earlier. Support Care Cancer (2016) 0.75
Worrying about one's children after breast cancer diagnosis: desired timing of psychosocial intervention. Support Care Cancer (2014) 0.75
Quality of life after radical prostatectomy or watchful waiting. N Engl J Med (2002) 6.83
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet (2008) 3.14
Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study. Eur Urol (2011) 2.62
Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden. Lancet Oncol (2010) 2.56
Prostate-specific antigen levels as a predictor of lethal prostate cancer. J Natl Cancer Inst (2007) 2.49
Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study. J Natl Cancer Inst (2010) 2.45
Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden. Eur Urol (2009) 2.37
Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden. J Urol (2008) 2.17
Multiple events of fractures and cardiovascular and thromboembolic disease following prostate cancer diagnosis: results from the population-based PCBaSe Sweden. Eur Urol (2011) 2.10
Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum Mol Genet (2009) 1.90
Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0. Int J Epidemiol (2012) 1.88
Outcome of primary versus deferred radical prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study. J Urol (2010) 1.75
Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol (2007) 1.68
Parents' intellectual and emotional awareness of their child's impending death to cancer: a population-based long-term follow-up study. Lancet Oncol (2007) 1.67
Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden. J Clin Oncol (2010) 1.62
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. Proc Natl Acad Sci U S A (2010) 1.59
A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk. Eur Urol (2012) 1.55
Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts. Eur Urol (2009) 1.49
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet (2012) 1.47
Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol (2011) 1.42
Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristics. J Clin Oncol (2011) 1.39
[In Process Citation]. Lakartidningen (2015) 1.38
Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer. Prostate (2009) 1.33
Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer. Clin Cancer Res (2004) 1.32
Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer. Prostate (2010) 1.20
The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival. Scand J Urol Nephrol (2005) 1.20
Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway. Prostate (2006) 1.19
Effects of prostate-specific antigen testing on familial prostate cancer risk estimates. J Natl Cancer Inst (2010) 1.17
PCBaSe Sweden: a register-based resource for prostate cancer research. Scand J Urol Nephrol (2009) 1.17
Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR. Clin Cancer Res (2003) 1.16
Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism. Int J Cancer (2007) 1.15
Genetic variants and family history predict prostate cancer similar to prostate-specific antigen. Clin Cancer Res (2009) 1.09
A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years. Scand J Urol Nephrol (2003) 1.01
Impact of comorbidity on management and mortality in women diagnosed with breast cancer. Breast Cancer Res Treat (2012) 0.99
Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden. Scand J Urol Nephrol (2010) 0.98
Long-term effects of widowhood after terminal cancer: a Swedish nationwide follow-up. Scand J Public Health (2003) 0.97
Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study. Breast Cancer Res Treat (2012) 0.97
How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden. Cancer Causes Control (2013) 0.97
Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden. Eur Urol (2011) 0.96
Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register. Scand J Urol (2014) 0.96
Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden. Breast Cancer Res Treat (2011) 0.96
Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development. Cancer Res (2006) 0.94
Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study. J Clin Oncol (2012) 0.94
Hip fractures in men with prostate cancer treated with orchiectomy. J Urol (2004) 0.93
Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years. Breast Cancer Res Treat (2009) 0.92
Incidence of fractures causing hospitalisation in prostate cancer patients: results from the population-based PCBaSe Sweden. Eur J Cancer (2012) 0.92
Tobacco prevention in Swedish dental care. Community Dent Oral Epidemiol (2003) 0.91
Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden. Scand J Urol Nephrol (2009) 0.91
Psychiatric treatment in men with prostate cancer--results from a Nation-wide, population-based cohort study from PCBaSe Sweden. Eur J Cancer (2011) 0.90
Risk of suicide in men with low-risk prostate cancer. Eur J Cancer (2013) 0.89
Season of diagnosis and prognosis in breast and prostate cancer. Cancer Causes Control (2008) 0.89
Primary cancers before and after prostate cancer diagnosis. Cancer (2012) 0.89
Clinical course of bladder neoplasms and single nucleotide polymorphisms in the CDKN2A gene. Int J Cancer (2003) 0.88
Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer. Eur J Cancer (2011) 0.88
Interleukin-6 sequence variants are not associated with prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2004) 0.87
Awareness of husband's impending death from cancer and long-term anxiety in widowhood: a nationwide follow-up. Palliat Med (2004) 0.87
The management of category T1a-T1b (incidental) prostate cancer: can we predict who needs treatment? Eur Urol (2008) 0.86
The Internet and prostate cancer patients: searching for and finding information. Scand J Urol Nephrol (2007) 0.85
Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP. Hum Genet (2005) 0.85
Risk of in-hospital complications after radical cystectomy for urinary bladder carcinoma: population-based follow-up study of 7608 patients. BJU Int (2013) 0.84
Mortality following hip fracture in men with prostate cancer. PLoS One (2013) 0.84
A single-nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle-invasive neoplasms of the urinary bladder. BJU Int (2006) 0.82
Concordance of tumor differentiation among brothers with prostate cancer. Eur Urol (2012) 0.80
Y chromosome haplotypes and prostate cancer in Sweden. Clin Cancer Res (2008) 0.80
Disseminating evidence from health technology assessment: the case of tobacco prevention. Int J Technol Assess Health Care (2006) 0.79
Bladder neoplasms--regions at chromosome 9 with putative tumour suppressor genes. Scand J Urol Nephrol (2003) 0.78
Economic conditions and marriage quality of men with prostate cancer. BJU Int (2007) 0.78
Differences in survival from prostate cancer in Denmark, Iceland and Sweden. Eur J Cancer (2013) 0.78
The choice between a therapy-induced long-term symptom and shortened survival due to prostate cancer. Eur Urol (2006) 0.78
Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden. Int J Cancer (2011) 0.78
Reliability of assessment of urgency and other symptoms indicating anal sphincter, large bowel or urinary dysfunction. Scand J Urol Nephrol (2006) 0.78
Prognostic significance of homozygous deletions and multiple duplications at the CDKN2A (p16INK4a)/ARF (p14ARF) locus in urinary bladder cancer. Scand J Urol Nephrol (2006) 0.78
Difference in hormone receptor content in breast cancers from Vietnamese and Swedish women. Acta Oncol (2011) 0.78
Quality indicators for palliative and end of life care: a review of Swedish policy documents. BMJ Support Palliat Care (2013) 0.78
Alcohol influence on acrylamide to glycidamide metabolism assessed with hemoglobin-adducts and questionnaire data. Food Chem Toxicol (2009) 0.77
Thromboembolic events following surgery for prostate cancer. Eur Urol (2012) 0.77
Editorial comment on: predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance. Eur Urol (2008) 0.75
Breast cancer associated with primary hyperparathyroidism: a nested case control study. Clin Epidemiol (2011) 0.75
Screening for prostate cancer - will we ever know? Acta Oncol (2010) 0.75
Editorial comment on: Pharmacological approaches to reducing the risk of prostate cancer. Eur Urol (2009) 0.75
Chairmen's summary. Scand J Urol Nephrol Suppl (2008) 0.75
Reply from Authors re: Goutham Vemana, Gerald L. Andriole. Bad Habits May Be Hard to Break. Eur Urol 2013;63:426-7: Changing Habits. Eur Urol (2012) 0.75
Epidemiology and statistical methods in prediction of patient outcome. Scand J Urol Nephrol Suppl (2005) 0.75
[More randomized studies in health care can be made cheaper and more regularly]. Lakartidningen (2013) 0.75
Placental weight and mortality in premenopausal breast cancer by tumor characteristics. Breast Cancer Res Treat (2012) 0.75
The time course of semantic and associative priming effects is different in an attentional blink task. Cogn Process (2013) 0.75
Predictors for the symptomatic prostate cancer patient's delays in seeking care. Eur J Cancer (2008) 0.75
Birth size in the most recent pregnancy and maternal mortality in premenopausal breast cancer by tumor characteristics. Breast Cancer Res Treat (2014) 0.75
The Nordic Nutrition Recommendations and prostate cancer risk in the Cancer of the Prostate in Sweden (CAPS) study. Public Health Nutr (2012) 0.75
Need for and access to bereavement support after loss of a husband to urologic cancers: a nationwide follow-up of Swedish widows. Scand J Urol Nephrol (2005) 0.75